WP
WayPath Pharma specializes in the development of small molecule therapeutics targeting specific cancer pathways to enhance treatment efficacy. The company addresses the challenge of limited treatment options for various cancer types by providing targeted therapies that improve patient outcomes.
Updated 20 months ago
Funding
$225K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NC
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- WayPath Pharma specializes in the development of small molecule therapeutics targeting specific cancer pathways to enhance treatment efficacy. The company addresses the challenge of limited treatment options for various cancer types by providing targeted therapies that improve patient outcomes.